NCT06038786 is a NA clinical trial of Resilience Training in Psychotic Disorders, sponsored by Massachusetts General Hospital.

Who is sponsoring NCT06038786?

NCT06038786 is sponsored by Massachusetts General Hospital.

What drugs are being tested in NCT06038786?

Interventions in NCT06038786: Resilience Training.

What condition does NCT06038786 study?

NCT06038786 studies Psychotic Disorders, Mood Disorders, Anxiety Disorders.

Is NCT06038786 still recruiting?

NCT06038786 is currently completed. Last updated 15 September 2023.

Last reviewed 2023-09-15 · How we verify

NCT06038786

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Resiliency Training on the College Campus

Completed NA Last updated 15 September 2023

What this trial tests

NA trial testing Resilience Training in Psychotic Disorders in 107 participants. Completed in 1 March 2020.

Timeline

1 July 2018

Primary endpoint
26 November 2019

1 March 2020

Quick facts

Lead sponsor	Massachusetts General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	107
Start date	1 July 2018
Primary completion	26 November 2019
Estimated completion	1 March 2020
Sites	1 location across United States

Drugs / interventions tested

Resilience Training

Conditions studied

Psychotic Disorders — all drugs for Psychotic Disorders →
Mood Disorders — all drugs for Mood Disorders →
Anxiety Disorders — all drugs for Anxiety Disorders →

Sponsor

Massachusetts General Hospital

Who can join

Adults 18 to 30, any sex, with Psychotic Disorders or Mood Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a waitlist controlled study examining the initial efficacy of Resilience Training among college students at an elevated risk for a severe mental illness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Brief Resilience-Enhancing Intervention and Loneliness in At-Risk Young Adults: A Secondary Analysis of a Randomized Clinical Trial.
DeTore NR, Burke A, Nyer M, Holt DJ. · · 2024 · cited 10× · PMID 38315488 · DOI 10.1001/jamanetworkopen.2023.54728

Verify or expand the search:

Other trials of Resilience Training

Trials testing the same drug.

NCT06360562 — Reconnecting to Ourselves and Others in Virtual Meetings (ROOM) · NA · active not recruiting

Other recruiting trials for Psychotic Disorders

Currently open trials in the same condition.

NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting

Other Massachusetts General Hospital trials

Trials by the same sponsor.

NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06038786 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 15 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06038786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing